Massachusetts Financial Services’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-379,152
| Closed | -$6.34M | – | 920 |
|
|
2020
Q2 | $6.34M | Buy |
379,152
+30,633
| +9% | +$512K | ﹤0.01% | 631 |
|
|
2020
Q1 | $5.03M | Buy |
348,519
+38,659
| +12% | +$558K | ﹤0.01% | 633 |
|
|
2019
Q4 | $10.4M | Sell |
309,860
-231,357
| -43% | -$7.74M | ﹤0.01% | 598 |
|
|
2019
Q3 | $11.3M | Buy |
541,217
+119,008
| +28% | +$2.49M | ﹤0.01% | 597 |
|
|
2019
Q2 | $8.79M | Buy |
422,209
+2,507
| +0.6% | +$52.2K | ﹤0.01% | 636 |
|
|
2019
Q1 | $9.38M | Sell |
419,702
-272
| -0.1% | -$6.08K | ﹤0.01% | 619 |
|
|
2018
Q4 | $10M | Buy |
419,974
+95,993
| +30% | +$2.3M | ﹤0.01% | 595 |
|
|
2018
Q3 | $8.84M | Buy |
323,981
+63,546
| +24% | +$1.73M | ﹤0.01% | 642 |
|
|
2018
Q2 | $7M | Buy |
260,435
+37,053
| +17% | +$996K | ﹤0.01% | 659 |
|
|
2018
Q1 | $7.11M | Buy |
+223,382
| New | +$7.11M | ﹤0.01% | 649 |
|